Medannex Ltd
PrivateLast Round
Grant
May 11, 2026
Total Funding Raised
$29.07M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Medannex Ltd is a biotechnology company that develops novel monoclonal antibody therapeutics to treat cancers and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medannex Ltd Comparables
Compare Medannex Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Netris Pharma | 81% | |
| Alligator Bioscience | 69% | |
| Phanes Therapeutics | 69% |
Medannex Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 11, 2026 | ||||
| Grant | Jul 25, 2024 | ||||
| Series B | Aug 17, 2020 | ||||
| Series B | Mar 5, 2020 | ||||
| Grant | Jan 1, 2019 | ||||
Grant | Jun 12, 2018 |
Key People
Founding team and executive leadership
Medannex Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Ventures | Series B |
| Innovate UK | Grant |
| Morningside Group | Series B |
| Scottish Investment Bank (Scottish Enterprise) | Series B, Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 102% MoM.
- May 11, 2026
$130K grant received from Scottish Investment Bank
Medannex Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Medannex Ltd's valuation, stock price, and market status.
Is Medannex Ltd a public or private company?
Medannex Ltd is a private company.
What is the current stock price of Medannex Ltd?
Medannex Ltd is a private company with no public stock price. Caplight tracks Medannex Ltd's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Medannex Ltd worth (valuation)?
Valuation information for Medannex Ltd is not publicly available.
Can I buy Medannex Ltd stock?
Medannex Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Medannex Ltd's last funding round?
Medannex Ltd's most recent funding round was Grant on May 11, 2026.
Who are the main investors in Medannex Ltd?
Key investors in Medannex Ltd include Morningside Ventures.
Will Medannex Ltd IPO soon?
No public IPO plans have been announced for Medannex Ltd.
How can I track Medannex Ltd secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medannex Ltd's secondary market activity and sign up for updates.